Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns a pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.
| Last: | $1e-06 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $1e-06 |
| Close: | $1e-06 |
| High: | $1e-06 |
| Low: | $1e-06 |
| Volume: | 125 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
| Market Cap: | $59 |
|---|---|
| Float: | 57,837,089 |
| Insiders Ownership: | 1.4% |
| Institutions: | 30 |
| Short Percent: | 1637397% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.genocea.com |
| Country: | US |
| City: | Cambridge |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Genocea Biosciences Inc. (OTCMKTS: GNCAQ).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
